KHC
29
2
HST
40
2
HBAN
33
2
ICE
67
3
SCHW
49
3
KMI
55
-4
WRK
60
-3
AIZ
64
-2
DO
45
2
MLM
63
2
CVX
23
-2
VMC
57
3
TGNA
58
4
MMM
30
2
ILMN
36
10
SLG
71
-4
AEP
56
-2
BBY
55
-2
CB
58
-2
RHI
43
15
KHC
29
2
HST
40
2
HBAN
33
2
ICE
67
3
SCHW
49
3
KMI
55
-4
WRK
60
-3
AIZ
64
-2
DO
45
2
MLM
63
2
CVX
23
-2
VMC
57
3
TGNA
58
4
MMM
30
2
ILMN
36
10
SLG
71
-4
AEP
56
-2
BBY
55
-2
CB
58
-2
RHI
43
15
Financhill
Back

Pliant Therapeutics Stock Predictions

Sell
45

PLRX
Pliant Therapeutics

Last Price:
10.98
Seasonality Move:
50.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Pliant Therapeutics Stock Forecast

  • Over the next 52 weeks, Pliant Therapeutics has on average historically risen by 29.6% based on the past 4 years of stock performance.
  • Pliant Therapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
  • Is Pliant Therapeutics Stock Undervalued?
    The current Pliant Therapeutics [PLRX] share price is $10.99. The Score for PLRX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • PLRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Pliant Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Pliant Therapeutics has on average historically risen by 29.6% based on the past 4 years of stock performance.

Pliant Therapeutics Stock Rating

Sell
45
Pliant Therapeutics (PLRX) is a Sell

Is Pliant Therapeutics overpriced?

  • Pliant Therapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%

Pliant Therapeutics Stock Price History

Is PLRX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
pliantrx.com

52-Week Data

52-Week High:
21.21
52-Week Low:
10.43

Prediction Charts

Market Cap:
662.98M
Price in USD:
10.99
Volume:
944.7K
Beta:
1.21

Technical Analysis

SMA50:
12.82
SMA100:
14.27
SMA200:
15.08
52-Wk Change:
-49.12%

Stock Predictions

  • Is Pliant Therapeutics stock public?
    Yes, Pliant Therapeutics is a publicly traded company.
  • What is the Pliant Therapeutics stock quote today?
    The Pliant Therapeutics stock price is 10.99 USD today.
  • How to buy Pliant Therapeutics stock online?
    You can buy Pliant Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-3 12.38 12.03 12.86 11.79
Jun-4 11.99 12.14 12.31 11.76
Jun-5 12.24 12.10 12.43 11.91
Jun-6 12.26 11.54 12.27 11.44
Jun-7 11.20 11.15 11.78 10.94
Jun-10 11.06 11.51 11.52 10.60
Jun-11 11.42 11.29 11.44 11.02
Jun-12 11.87 11.76 12.04 11.60
Jun-13 11.74 11.97 12.38 11.74
Jun-14 11.83 11.80 12.03 11.67
Jun-17 11.66 11.20 11.91 11.08
Jun-18 11.17 10.71 11.23 10.43
Jun-20 10.64 10.74 10.85 10.52
Jun-21 10.82 10.99 11.17 10.80

Pliant Therapeutics Earnings

Pliant Therapeutics Earnings Report: Per Share Pliant Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Pliant Therapeutics Forecast Revenue Growth

Pliant Therapeutics Stock Analysis: Historical quarterly revenues per share for Pliant Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.27 per share.

* Pliant Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.